(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Crohn’s Disease pipeline constitutes 40+ key companies continuously working towards developing 50+ Crohn’s Disease treatment therapies, analysis of Clinical Trials,
FDA Approves RHB-204 for Crohn’s Disease: Market Impact Analysis by DelveInsight | AstraZeneca, Immunic, Suzhou Connect Biopharma, Pfizer, Bristol-Myers Squibb
The Key Myasthenia Gravis Companies in the market include – Alexion, AstraZeneca, Argenx, Novartis, Alpine Immune Science, Toleranzia, Cabaletta Bio, Rallybio, Alexion Pharmaceuticals, Takeda, Cartesian Therapeutics, RemeGen, Horizon Therapeutics, and
DelveInsight’s “JAK Inhibitor Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the JAK Inhibitor pipeline landscape. It covers the JAK Inhibitor pipeline drug
DelveInsight’s “Glioblastoma Pipeline Insight, 2026” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Glioblastoma pipeline landscape. It covers the Glioblastoma pipeline drug profiles, including clinical and
DelveInsight’s “ESCLC Pipeline Insight, 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the ESCLC pipeline landscape. It covers the ESCLC pipeline drug profiles, including clinical
DelveInsight’s, “RNA Interference Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 90+ pipeline drugs in the RNA Interference pipeline landscape. It covers the RNA Interference pipeline drug
DelveInsight’s “Gout Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Gout pipeline landscape. It covers the Gout Pipeline drug profiles, including clinical
DelveInsight’s, “Eczema Pipeline Insights 2026” Report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Eczema pipeline landscape. It covers the Eczema pipeline drug profiles, including clinical and
The latest market forecast report provides an in-depth analysis of the Sleep Tech Devices Market, offering comprehensive insights into the
Emerging Non-Muscle Invasive Bladder Cancer therapies including CG0070 (CG Oncology), Sasanlimab (Pfizer), EG-70 (enGene), TAR-200 and TAR-210 (Johnson & Johnson),
The Prader-Willi Syndrome (PWS) market is witnessing steady growth, driven by increasing disease awareness, improving diagnostic capabilities, wider adoption of
The Cold Agglutinin Disease (CAD) market is witnessing steady growth, driven by increasing disease awareness, improving diagnosis rates, growing adoption
The Morquio Syndrome market is witnessing steady growth, driven by increasing awareness and diagnosis of rare genetic disorders, wider adoption
Key Schizophrenia companies such as Boehringer Ingelheim, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Karuna Therapeutics,
Mordor Intelligence has published a new report on smart retinal implants market, offering a comprehensive analysis of trends, growth drivers,
Mordor Intelligence has published a new report on medication adherence market, offering a comprehensive analysis of trends, growth drivers, and
United States Securities Brokerage Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the
Lithium Market Mordor Intelligence has published a new report on the lithium market, offering a comprehensive analysis of trends, growth
Decorative Laminates Market Mordor Intelligence has published a new report on the decorative laminates market, offering a comprehensive analysis of
Solar-Powered Irrigation System Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the solar-powered
